Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
4.310
+0.160 (3.86%)
Sep 1, 2026, 11:43 AM EDT - Market open
Clover Health Investments Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 2,447 | 1,892 | 1,345 | 1,243 | 1,178 | 688.79 |
Gain (Loss) on Sale of Investments | 0.57 | 0.98 | 0.01 | -4.71 | 8.95 | -0.05 |
Non-Insurance Activities Revenue | - | - | - | - | - | 667.64 |
Other Revenue | 28.39 | 30.8 | 25.77 | 24.75 | 11.95 | 5 |
| 2,476 | 1,924 | 1,371 | 1,263 | 1,199 | 1,361 | |
Revenue Growth | 53.98% | 40.33% | 8.52% | 5.32% | -11.91% | 97.30% |
Policy Benefits | 2,017 | 1,568 | 1,006 | 1,005 | 993.07 | 1,551 |
Depreciation & Amortization | 1.91 | 1.69 | 1.33 | 2.51 | 1.19 | 1.25 |
Selling, General & Administrative | 332.42 | 317.93 | 290.81 | 324.02 | 367.98 | 349.01 |
Other Operating Expenses | -0.8 | -0.8 | - | - | 0.07 | 0.19 |
Total Operating Expenses | 2,494 | 2,009 | 1,417 | 1,447 | 1,477 | 1,998 |
Operating Income | -18.36 | -85.53 | -45.93 | -184.29 | -277.45 | -636.99 |
Interest Expense | - | - | - | -0.01 | -1.36 | -16.91 |
Other Non Operating Income (Expenses) | -0 | -0.02 | -0.05 | -0.09 | 0.9 | 66.15 |
EBT Excluding Unusual Items | -18.36 | -85.55 | -45.98 | -184.38 | -277.91 | -587.76 |
Merger & Restructuring Charges | - | - | -0.29 | -9.82 | - | - |
Impairment of Goodwill | - | - | - | -11.7 | - | - |
Asset Writedown | - | - | - | -4.25 | - | - |
Other Unusual Items | - | - | - | - | 23.33 | - |
Pretax Income | -18.36 | -85.55 | -46.27 | -210.15 | -254.58 | -587.76 |
Earnings From Continuing Ops. | -18.36 | -85.55 | -46.27 | -210.15 | -254.58 | -587.76 |
Earnings From Discontinued Ops. | - | - | 3.26 | -3.21 | -84.98 | - |
Net Income | -18.36 | -85.55 | -43.01 | -213.36 | -339.57 | -587.76 |
Net Income to Common | -18.36 | -85.55 | -43.01 | -213.36 | -339.57 | -587.76 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 519 | 512 | 490 | 482 | 476 | 413 |
Shares Outstanding (Diluted) | 519 | 512 | 490 | 482 | 476 | 413 |
Shares Change | 3.75% | 4.48% | 1.63% | 1.25% | 15.33% | 365.57% |
EPS (Basic) | -0.04 | -0.17 | -0.09 | -0.44 | -0.71 | -1.42 |
EPS (Diluted) | -0.04 | -0.17 | -0.09 | -0.44 | -0.71 | -1.42 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 74.21 | -68.98 | 33.29 | -145.25 | -208.39 | -283.05 |
Free Cash Flow Per Share | 0.14 | -0.14 | 0.07 | -0.30 | -0.44 | -0.69 |
Operating Margin | -0.74% | -4.45% | -3.35% | -14.59% | -23.13% | -46.79% |
Profit Margin | -0.74% | -4.45% | -3.14% | -16.89% | -28.31% | -43.17% |
Free Cash Flow Margin | 3.00% | -3.59% | 2.43% | -11.50% | -17.38% | -20.79% |
EBITDA | -17.96 | -85.34 | -45.8 | -182.78 | -276.26 | -635.75 |
EBITDA Margin | -0.73% | -4.44% | -3.34% | -14.47% | -23.04% | -46.70% |
D&A For EBITDA | 0.41 | 0.19 | 0.13 | 1.51 | 1.19 | 1.25 |
EBIT | -18.36 | -85.53 | -45.93 | -184.29 | -277.45 | -636.99 |
EBIT Margin | -0.74% | -4.45% | -3.35% | -14.59% | -23.13% | -46.79% |